Culin5 aggravates hypoxic pulmonary hypertension by activating TRAF6/NF-κB/HIF-1α/VEGF

Summary: Hypoxic pulmonary hypertension (HPH) lacks effective pharmacologic treatments. Microarray-based gene expression indicates the crucial role of Cullin 5 (Cul 5) in HPH. This study showed that Cul 5 was upregulated in HPH patients and a murine model of HPH. In vitro, Cul 5 promoted the angioge...

Full description

Bibliographic Details
Main Authors: Lei Wang, Jing Huang, Ruoyang Zhang, Muzhi Zhang, Yu Guo, Yang Liu, Cong Li, Wei Wang, Sun Ying, Jie Liu, Chen Wang
Format: Article
Language:English
Published: Elsevier 2023-11-01
Series:iScience
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2589004223022769
_version_ 1797647840711802880
author Lei Wang
Jing Huang
Ruoyang Zhang
Muzhi Zhang
Yu Guo
Yang Liu
Cong Li
Wei Wang
Sun Ying
Jie Liu
Chen Wang
author_facet Lei Wang
Jing Huang
Ruoyang Zhang
Muzhi Zhang
Yu Guo
Yang Liu
Cong Li
Wei Wang
Sun Ying
Jie Liu
Chen Wang
author_sort Lei Wang
collection DOAJ
description Summary: Hypoxic pulmonary hypertension (HPH) lacks effective pharmacologic treatments. Microarray-based gene expression indicates the crucial role of Cullin 5 (Cul 5) in HPH. This study showed that Cul 5 was upregulated in HPH patients and a murine model of HPH. In vitro, Cul 5 promoted the angiogenesis and adhesion capacity of human pulmonary artery endothelial cells (PAECs), which could be mitigated by Cul 5 inactivation mediated by pevonedistat or NEDD8 silence. In vivo, silencing of Cul 5 in the endothelium and Cul 5 inactivation by pevonedistat could also alleviate hypoxic vascular remodeling. Mechanistic research showed that Cul 5 participated in HPH pathogenesis via the TRAF6/NF-κB/HIF-1α/VEGF pathway. Inhibition of the TRAF6/NF-κB/HIF-1α/VEGF pathway could reverse Cul 5-induced human PAEC dysfunction. These findings demonstrate that Cul 5 is an important mediator of HPH via the TRAF6/NF-κB/HIF-1α/VEGF pathway firstly, and could be considered as a potential therapeutic target in the clinical treatment of HPH.
first_indexed 2024-03-11T15:22:20Z
format Article
id doaj.art-afccc7e7dc774dff9856e60cc20b574d
institution Directory Open Access Journal
issn 2589-0042
language English
last_indexed 2024-03-11T15:22:20Z
publishDate 2023-11-01
publisher Elsevier
record_format Article
series iScience
spelling doaj.art-afccc7e7dc774dff9856e60cc20b574d2023-10-28T05:09:29ZengElsevieriScience2589-00422023-11-012611108199Culin5 aggravates hypoxic pulmonary hypertension by activating TRAF6/NF-κB/HIF-1α/VEGFLei Wang0Jing Huang1Ruoyang Zhang2Muzhi Zhang3Yu Guo4Yang Liu5Cong Li6Wei Wang7Sun Ying8Jie Liu9Chen Wang10Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Xi’an Jiaotong University (Xibei Hospital), Xi’an, Shaanxi 710004, China; Department of Respiratory Medicine, Capital Medical University, Beijing 100054, P.R. ChinaDepartment of Rheumatism and Immunology, The First Affiliated Hospital Xi’an Jiaotong University, Xi’an, Shaanxi 710061, ChinaDepartment of Immunology, School of Basic Medical Sciences, Capital Medical University, Beijing 100054, China; Department of Respiratory Medicine, Capital Medical University, Beijing 100054, P.R. ChinaDepartment of Immunology, School of Basic Medical Sciences, Capital Medical University, Beijing 100054, China; Department of Respiratory Medicine, Capital Medical University, Beijing 100054, P.R. ChinaDepartment of Immunology, School of Basic Medical Sciences, Capital Medical University, Beijing 100054, China; Department of Respiratory Medicine, Capital Medical University, Beijing 100054, P.R. ChinaDepartment of Immunology, School of Basic Medical Sciences, Capital Medical University, Beijing 100054, China; Department of Respiratory Medicine, Capital Medical University, Beijing 100054, P.R. ChinaDepartment of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Xi’an Jiaotong University (Xibei Hospital), Xi’an, Shaanxi 710004, ChinaDepartment of Immunology, School of Basic Medical Sciences, Capital Medical University, Beijing 100054, China; Department of Respiratory Medicine, Capital Medical University, Beijing 100054, P.R. ChinaDepartment of Immunology, School of Basic Medical Sciences, Capital Medical University, Beijing 100054, China; Department of Respiratory Medicine, Capital Medical University, Beijing 100054, P.R. ChinaDepartment of Immunology, School of Basic Medical Sciences, Capital Medical University, Beijing 100054, China; Department of Respiratory Medicine, Capital Medical University, Beijing 100054, P.R. China; Corresponding authorDepartment of Respiratory Medicine, Capital Medical University, Beijing 100054, P.R. ChinaSummary: Hypoxic pulmonary hypertension (HPH) lacks effective pharmacologic treatments. Microarray-based gene expression indicates the crucial role of Cullin 5 (Cul 5) in HPH. This study showed that Cul 5 was upregulated in HPH patients and a murine model of HPH. In vitro, Cul 5 promoted the angiogenesis and adhesion capacity of human pulmonary artery endothelial cells (PAECs), which could be mitigated by Cul 5 inactivation mediated by pevonedistat or NEDD8 silence. In vivo, silencing of Cul 5 in the endothelium and Cul 5 inactivation by pevonedistat could also alleviate hypoxic vascular remodeling. Mechanistic research showed that Cul 5 participated in HPH pathogenesis via the TRAF6/NF-κB/HIF-1α/VEGF pathway. Inhibition of the TRAF6/NF-κB/HIF-1α/VEGF pathway could reverse Cul 5-induced human PAEC dysfunction. These findings demonstrate that Cul 5 is an important mediator of HPH via the TRAF6/NF-κB/HIF-1α/VEGF pathway firstly, and could be considered as a potential therapeutic target in the clinical treatment of HPH.http://www.sciencedirect.com/science/article/pii/S2589004223022769Cardiovascular medicineMolecular physiologyMolecular medicine
spellingShingle Lei Wang
Jing Huang
Ruoyang Zhang
Muzhi Zhang
Yu Guo
Yang Liu
Cong Li
Wei Wang
Sun Ying
Jie Liu
Chen Wang
Culin5 aggravates hypoxic pulmonary hypertension by activating TRAF6/NF-κB/HIF-1α/VEGF
iScience
Cardiovascular medicine
Molecular physiology
Molecular medicine
title Culin5 aggravates hypoxic pulmonary hypertension by activating TRAF6/NF-κB/HIF-1α/VEGF
title_full Culin5 aggravates hypoxic pulmonary hypertension by activating TRAF6/NF-κB/HIF-1α/VEGF
title_fullStr Culin5 aggravates hypoxic pulmonary hypertension by activating TRAF6/NF-κB/HIF-1α/VEGF
title_full_unstemmed Culin5 aggravates hypoxic pulmonary hypertension by activating TRAF6/NF-κB/HIF-1α/VEGF
title_short Culin5 aggravates hypoxic pulmonary hypertension by activating TRAF6/NF-κB/HIF-1α/VEGF
title_sort culin5 aggravates hypoxic pulmonary hypertension by activating traf6 nf κb hif 1α vegf
topic Cardiovascular medicine
Molecular physiology
Molecular medicine
url http://www.sciencedirect.com/science/article/pii/S2589004223022769
work_keys_str_mv AT leiwang culin5aggravateshypoxicpulmonaryhypertensionbyactivatingtraf6nfkbhif1avegf
AT jinghuang culin5aggravateshypoxicpulmonaryhypertensionbyactivatingtraf6nfkbhif1avegf
AT ruoyangzhang culin5aggravateshypoxicpulmonaryhypertensionbyactivatingtraf6nfkbhif1avegf
AT muzhizhang culin5aggravateshypoxicpulmonaryhypertensionbyactivatingtraf6nfkbhif1avegf
AT yuguo culin5aggravateshypoxicpulmonaryhypertensionbyactivatingtraf6nfkbhif1avegf
AT yangliu culin5aggravateshypoxicpulmonaryhypertensionbyactivatingtraf6nfkbhif1avegf
AT congli culin5aggravateshypoxicpulmonaryhypertensionbyactivatingtraf6nfkbhif1avegf
AT weiwang culin5aggravateshypoxicpulmonaryhypertensionbyactivatingtraf6nfkbhif1avegf
AT sunying culin5aggravateshypoxicpulmonaryhypertensionbyactivatingtraf6nfkbhif1avegf
AT jieliu culin5aggravateshypoxicpulmonaryhypertensionbyactivatingtraf6nfkbhif1avegf
AT chenwang culin5aggravateshypoxicpulmonaryhypertensionbyactivatingtraf6nfkbhif1avegf